ANI
04 Oct 2023, 01:27 GMT+10
Pune (Maharashtra) [India], October 3 (ANI): As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.
"This will save thousands of lives in Africa afflicted by Malaria, and help bridge the vast gap between the demand and supply of vaccines to fight this terrible disease," he wrote on X, as he thanked WHO for the milestone achieved.
On Monday, the R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
Following a rigorous, detailed scientific review by the WHO's independent advisory body, the Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG), the R21/Matrix-M malaria vaccine has been recommended for use.
"The recommendation was based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission, making it the world's second-ever WHO recommended vaccine for preventing malaria in children," Serum Institute of India said in a statement on Monday.
The vaccine was developed by the Jenner Institute at Oxford University and Serum Institute of India with support from the European and Developing Countries Clinical Trials Partnership ('EDCTP'), the Wellcome Trust, and the European Investment Bank ('EIB').
To date, the R21/Matrix-M malaria vaccine has been licensed for use in Ghana, Nigeria and Burkina Faso.
"In combination with public health measures such as the use of insecticide-treated bed nets, this vaccine can help save and improve the lives of millions of children and their families," SII added.
The vaccine has recently reached the primary one-year endpoint in a pivotal large-scale Phase III clinical trial- funded mainly by the Serum Institute of India, with Oxford University as the regulatory sponsor - including 4,800 children across Burkina Faso, Kenya, Mali and Tanzania. The Phase III trial results are under peer review before publication.
Serum Institute of India further said that with the approval and recommendations by the WHO, additional regulatory approvals are expected to follow shortly and R21/Matrix-M vaccine doses could be ready to begin wider roll-out as early as next year. (ANI)
Get a daily dose of Hong Kong Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Hong Kong Herald.
More InformationBENTONVILLE, Arkansas: As part of its efforts to reduce reliance on China, cut costs, and diversify its supply chains, Walmart, ...
NAYPYIDAW, Myanmar: Kyar Win, spokesperson for the Myanmar National Democratic Alliance Army, which launched a surprise offensive last month against ...
BEIJING, China: The country's commerce ministry said that during a meeting with Vietnamese Prime Minister Pham Minh Chinh in Ho ...
© Provided by Xinhua From top executives and editors-in-chief to seasoned journalists and media scholars, as well as press officials, ...
© Provided by Xinhua A delegation of China's manned space program are on a six-day visit to Hong Kong and ...
(Photo credit: Sam Navarro-USA TODAY Sports) Sophia Smith scored early in a rare start at center forward and the U.S. ...
WASHINGTON D.C.: This week, the White House said that Senior Biden administration officials met with the makers of respiratory syncytial ...
CHEYENNE, Wyoming: This week, the Biden administration raised US$3.4 million from a sale of oil and gas drilling rights in ...
NEW YORK, New York - U.S. stocks extended their rally on Friday despite remarks by Federal Reserve Chair Jerome Powell ...
MOSCOW, Russia: Russia's trade in oil with India, one of the most lucrative oil trade routes since the imposition of ...
LONDON - Health experts and tobacco campaigners have strongly criticized New Zealand's decision to repeal laws that aimed to ban ...
NEW YORK, New York - The Dow Jones index was the standout on U.S. financial markets on Thursday with a ...